Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression. Butt AA, Yan P, Shaikh OS. PLoS One 2024;19:e0298254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Butt AA, Yan P, Shaikh OS. Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression. PLoS One 2024;19:e0298254.
PMID: 38843201